Expert Recommendations for Clinical Application of Trazodone Hydrochloride Sustained Release

PAN  Jiyang, FANG  Yiru, HU  Shaohua, LU  Zheng, SU  Changjun, TANG  Xiangdong, WANG  Tao, WANG  Wenqiang, YAO  Zhijian, YUAN  Yonggui, YU  Huan, ZHAN  Shuqin, ZHAO  Zhongxin, ZHANG  Xulai, ZHANG  Ling, LI  Lingjiang

doi:10.12114/j.issn.1007-9572.2022.0532

Zhongguo quanke yixue (Nov 2022)

Expert Recommendations for Clinical Application of Trazodone Hydrochloride Sustained Release

PAN Jiyang, FANG Yiru, HU Shaohua, LU Zheng, SU Changjun, TANG Xiangdong, WANG Tao, WANG Wenqiang, YAO Zhijian, YUAN Yonggui, YU Huan, ZHAN Shuqin, ZHAO Zhongxin, ZHANG Xulai, ZHANG Ling, LI Lingjiang

Affiliations

PAN Jiyang, FANG Yiru, HU Shaohua, LU Zheng, SU Changjun, TANG Xiangdong, WANG Tao, WANG Wenqiang, YAO Zhijian, YUAN Yonggui, YU Huan, ZHAN Shuqin, ZHAO Zhongxin, ZHANG Xulai, ZHANG Ling, LI Lingjiang: 1.The First Affiliated Hospital of Jinan University, Guangzhou 510000, China;2.Shanghai Mental Health Center, Shanghai 200000, China;3.The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou 310000, China;4.Tongji Hospital of Tongji University, Shanghai 200000, China;5.The Second Affiliated Hospital of Air Force Medical University, Xi'an 710000, China;6.West China Hospital Of Sichuan University, Chengdu 610000, China;7.Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China;8.Xiamen Mental Health Center, Xiamen 361000, China;9.The Affiliated Brain Hospital of Nanjing Medical University, Nanjing 210000, China;10.Zhongda Hospital Affilicated of Southeast University, Nanjing 210000, China;11.Huashan Hospital Affiliated to Fudan University, Shanghai 200000, China;12.Xuanwu Hospital Affiliated to Capital University of Medical Sciences, Beijing 100000, China;13.The Second Affiliated Hospital of Naval Medical University, Shanghai 200000, China;14.Mental Health Center in Anhui Province, Hefei 230000, China;15.Naning Fifth People's Hospital, Nanning 530000, China;16.The Second Xiangya Hospital of Central South University, Changsha 410000, China

DOI: https://doi.org/10.12114/j.issn.1007-9572.2022.0532
Journal volume & issue: Vol. 25, no. 33
pp. 4099 – 4105

Abstract

Read online

Trazodone hydrochloride sustained -release, as a multi-receptor binding drug, can exert different pharmacological effects at different doses and can improve a variety of psychiatric disorders. To further standardize the clinical application of trazodone hydrochloride sustained release, the expert writing group integrated domestic and international clinical trials, clinical practice guidelines, prescribing guidelines and clinical medication experience to prepare this expert recommendation for clinical application. This article mentions that trazodone hydrochloride sustained release is clinically applicable to depression, insomnia caused by various reasons, and also applied to generalized anxiety disorder, sexual dysfunction, post-traumatic stress disorder, substance dependence and withdrawal reactions and obsessive-compulsive disorder, and describes drug dosage, interactions, and precautions for use in special populations, with a view to providing clinicians with scientific and comprehensive medication guidance.

mental disorders|depression|anxiety|insomnia|trazodone|guidebook|therapeutic uses|trazodone hydrochloride sustained release agent

Published in Zhongguo quanke yixue

ISSN: 1007-9572 (Print)
Publisher: Chinese General Practice Publishing House Co., Ltd
Country of publisher: China
LCC subjects: Medicine
Website: https://www.chinagp.net/EN/1007-9572/home.shtml

About the journal

Abstract

Keywords